Clonidine and Hepatic calcification - a phase IV clinical study of FDA data


Hepatic calcification is found among people who take Clonidine, especially for people who are female, 40-49 old.

The phase IV clinical study analyzes which people take Clonidine and have Hepatic calcification. It is created by eHealthMe based on reports of 57,167 people who have side effects when taking Clonidine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 04, 2022

57,167 people reported to have side effects when taking Clonidine.
Among them, 14 people (0.02%) have Hepatic calcification.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 58,680 Clonidine users for its effectiveness, alternative drugs and more.

What is Hepatic calcification?

Hepatic calcification is found to be associated with 274 drugs and 105 conditions by eHealthMe.

Number of Clonidine and Hepatic calcification reports submitted per year:

Could Clonidine cause Hepatic calcification?

Gender of people who have Hepatic calcification when taking Clonidine *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Hepatic calcification when taking Clonidine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 92.31 %
  • 50-59: 0.0 %
  • 60+: 7.69 %

Common drugs people take besides Clonidine *:

  1. Acetaminophen: 13 people, 92.86%
  2. Prilosec: 13 people, 92.86%
  3. Colace: 13 people, 92.86%
  4. Lisinopril: 13 people, 92.86%
  5. Lopressor: 13 people, 92.86%
  6. Lortab: 13 people, 92.86%
  7. Crestor: 13 people, 92.86%
  8. Lunesta: 13 people, 92.86%
  9. Carafate: 13 people, 92.86%
  10. Aredia: 13 people, 92.86%

Common side effects people have besides Hepatic calcification *:

  1. Hepatic Steatosis (fatty liver disease): 14 people, 100.00%
  2. Fatigue (feeling of tiredness): 14 people, 100.00%
  3. Diarrhea: 14 people, 100.00%
  4. Joint Pain: 14 people, 100.00%
  5. Intervertebral Disc Degeneration (spinal disc degeneration): 13 people, 92.86%
  6. High Blood Cholesterol: 13 people, 92.86%
  7. Hot Flush (sudden feelings of heat): 13 people, 92.86%
  8. Hyperaesthesia: 13 people, 92.86%
  9. Injury: 13 people, 92.86%
  10. Weakness: 13 people, 92.86%

Common conditions people have *:

  1. Bone Loss: 13 people, 92.86%
  2. Renal Cell Carcinoma (a kidney cancer): 1 person, 7.14%
  3. Metastases To Bone (cancer spreads to bone): 1 person, 7.14%
  4. Disease Recurrence: 1 person, 7.14%
  5. Breast Cancer Metastatic: 1 person, 7.14%
  6. Breast Cancer: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Clonidine and have Hepatic calcification?

Check whether Hepatic calcification is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Hepatic calcification and when was it recovered:

Expand to all the drugs that have ingredients of clonidine:

Alternative drugs to, pros and cons of Clonidine:

Common Clonidine side effects:

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Hepatic calcification treatments and more:

COVID vaccines that are related to Hepatic calcification:

All the drugs that are associated with Hepatic calcification:

All the conditions that are associated with Hepatic calcification:

How the study uses the data?

The study uses data from the FDA. It is based on clonidine (the active ingredients of Clonidine) and Clonidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: